The Lipitor Warning for GLP-1 Drugmakers Pfizer’s Lipitor experience shows the structural risks that today’s GLP-1 innovators may soon face By Joe Renny March 23, 2026 8 min The Medicine Maker Share Summary Takeaways Listen Insight Report Clinical Scorecard Quiz Poll Top Institutions Top Thought Leaders